Functional chest pain: nociception and visceral hyperalgesia.
Functional chest pain is a common, yet poorly understood entity. The focus of this review is to explore the evolving research and clinical approaches with a particular emphasis on the sensory or afferent neuronal dysfunction of the esophagus as a key player in the manifestation of this pain syndrome. Although once regarded as a psychologic or esophageal motility disorder, recent advances have shown that many of these patients have visceral hyperalgesia. Whether visceral hypersensitivity is a central or peripheral perturbation of the gut-brain axis remains debatable. Response to empirical therapy with high-dose proton pump inhibitors, upper endoscopy, or prolonged recording of esophageal pH may identify gastroesophageal reflux disease as a source of chest pain. Esophageal balloon distension study can serve as a useful test for identifying hypersensitivity. Newer techniques, including functional magnetic resonance imaging, magnetoencephalogram, and cortical evoked potentials, are being investigated. High doses of proton pump inhibitors and low doses of tricyclic antidepressants or trazadone remain the mainstay of therapy, although several new approaches including theophylline have been shown to be beneficial.
Chahal
Premjit S
PS
Department of Internal Medicine, University of Iowa Carver College of Medicine Iowa City, IA 52242, USA.
Rao
Satish S C
SS
D002637:Chest Pain / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology*; D003937:Diagnosis, Differential; D005767:Gastrointestinal Diseases / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology; D006801:Humans; D006930:Hyperalgesia / Q000209:etiology / Q000503:physiopathology*; D009619:Nociceptors / Q000503:physiopathology*